We are live on ! Find out more
EC

Euclidean Capital Portfolio holdings

AUM $392M
1-Year Est. Return 31.85%
This Fund
S&P 500
This Quarter Est. Return
-0.41%
1 Year Est. Return
+31.85%
3 Year Est. Return
+76.27%
5 Year Est. Return
-20.16%
10 Year Est. Return
AUM
$266M
AUM Growth
-$471M
Cap. Flow
-$465M
Cap. Flow %
-174.9%
Top 10 Hldgs %
100%
Holding
11
New
Increased
1
Reduced
1
Closed

Top Buys

Rank Stock Value
1
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$59M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$524M

Sector Composition

Rank Sector Weight
1 Healthcare 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INDA icon
1
iShares MSCI India ETF
INDA
$6.89B
$125M 46.91%
2,425,144
VEU icon
2
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
$121M 45.4%
1,991,884
+978,450
+97% +$59M
FHTX icon
3
Foghorn Therapeutics
FHTX
$266M
$5.74M 2.16%
1,573,761
ORIC icon
4
Oric Pharmaceuticals
ORIC
$1.15B
$5.52M 2.07%
989,410
PMVP icon
5
PMV Pharmaceuticals
PMVP
$59.2M
$2.86M 1.08%
2,627,643
SPY icon
6
State Street SPDR S&P 500 ETF Trust
SPY
$795B
$2.3M 0.86%
4,104
-892,150
-100% -$524M
ALEC icon
7
Alector
ALEC
$168M
$1.61M 0.6%
1,307,858
SRZN icon
8
Surrozen
SRZN
$258M
$1.02M 0.38%
87,696
RAPT
9
DELISTED
RAPT Therapeutics
RAPT
$803K 0.3%
82,237
TNYA icon
10
Tenaya Therapeutics
TNYA
$161M
$579K 0.22%
1,015,705
SRZNW icon
11
Surrozen Inc Warrant
SRZNW
$5.13K ﹤0.01%
170,833

Similar funds

Euclidean Capital's Q1 2025 Portfolio in Review

As of Q1 2025, Euclidean Capital held 11 positions worth $266M, down 64% from $737M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Euclidean Capital withdrew a net $465M in Q1 2025, reducing 1 holding. Its largest reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $524M.

By sector, the portfolio is most concentrated in Healthcare at 6.8% of assets, up from 3.5% a quarter earlier.

Against the trend, Euclidean Capital added an estimated $59M to Vanguard FTSE All-World ex-US ETF.

  • Euclidean Capital added most to Vanguard FTSE All-World ex-US ETF in Q1 2025, an estimated $59M increase.
  • Euclidean Capital's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $524M.
  • Euclidean Capital's ten largest holdings make up 100% of its $266M portfolio in Q1 2025.
  • Euclidean Capital opened 0 new positions and closed 0 in Q1 2025.
  • Euclidean Capital's portfolio value fell 64% quarter-over-quarter to $266M.

Based on Euclidean Capital's 13F filing for Q1 2025, filed 15 May 2025.